Editorial: anti-TNF therapy-a double-edged sword? Authors' reply

Aliment Pharmacol Ther. 2019 Oct;50(7):823-824. doi: 10.1111/apt.15459.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Autoimmune Diseases*
  • Colitis, Ulcerative*
  • Crohn Disease*
  • Etanercept
  • Humans
  • Inflammatory Bowel Diseases*
  • Tumor Necrosis Factor-alpha

Substances

  • Tumor Necrosis Factor-alpha
  • Etanercept